OQROGet OQRO Pro
Insider trade

Merck (MRK)Officer sold ~$353K

Dalton E. Iii Smart, Officer at Merck, sold ~$353K of Merck shares.

~$353K
Approx. value · 4,262 sh @ $82.76
7,777.8
Holds after · shares reported
Traded
Apr 25, 2025
Filed
Apr 29, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 7, 2024CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  2. Sep 26, 2024CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  3. Feb 24, 2025CongressDisclosed purchase of MRK — reported range $15,001 - $50,000
  4. Feb 25, 2025CongressDisclosed sale of MRK — reported range $15,001 - $50,000
  5. Feb 26, 2025CongressDisclosed purchase of MRK — reported range $15,001 - $50,000
  6. Mar 3, 2025CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  7. Mar 19, 2025FDAFDA drug approval: Keytruda
  8. Mar 20, 2025CongressDisclosed partial sale of MRK — reported range $1,001 - $15,000
  9. Mar 31, 2025CongressDisclosed partial sale of MRK — reported range $15,001 - $50,000
  10. Apr 8, 2025CongressDisclosed purchase of MRK — reported range $15,001 - $50,000
  11. Apr 9, 2025CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  12. Apr 15, 2025FDAFDA drug approval: Welireg
  13. Apr 15, 2025FDAFDA drug approval: Welireg
  14. Apr 17, 2025CongressDisclosed sale of MRK — reported range $15,001 - $50,000
  15. Apr 21, 2025FDAFDA drug approval: Keytruda
  16. Apr 21, 2025CongressDisclosed sale of MRK — reported range $1,001 - $15,000
  17. Apr 25, 2025 · this disclosureInsiderOfficer sold ~$353K of MRK shares in the open market

What came next

  1. Apr 29, 2025CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  2. May 5, 2025CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  3. May 14, 2025FDAFDA drug approval: Welireg
  4. May 15, 2025CongressDisclosed sale of MRK — reported range $15,001 - $50,000
  5. May 22, 2025FDAFDA drug approval: Keytruda
  6. May 30, 2025CongressDisclosed sale of MRK — reported range $1,001 - $15,000
  7. Jun 3, 2025FDAFDA drug approval: Keytruda
  8. Jun 6, 2025FDAFDA drug approval: Keytruda
  9. Jun 9, 2025FDAFDA drug approval: Enflonsia
  10. Jun 12, 2025FDAFDA drug approval: Keytruda
  11. Jun 13, 2025CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  12. Jun 16, 2025CongressDisclosed sale of MRK — reported range $1,001 - $15,000
  13. Jun 24, 2025CongressDisclosed purchase of MRK — reported range $1,001 - $15,000
  14. Jul 11, 2025CongressDisclosed sale of MRK — reported range $1,001 - $15,000
  15. Jul 21, 2025FDARecall: Belsomra (suvorexant) tablets, 10mg, 30 Tablets in 3 Blister Cards per Carton, Each Blister Card contains 10 Tablets, Rx only, Merck Sharp & Dohme LLC, Rahway,…
  16. Jul 24, 2025FDAFDA drug approval: Keytruda
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Merck

For Merck, OQRO holds 26 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 123 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRK page.

Other recent filings by Dalton E. Iii Smart, SVP Fin. - Global Controller

The full history of Dalton E. Iii Smart, SVP Fin. - Global Controller is on the profile page.

How this filing works

Other disclosures at Merck

Everything OQRO holds on this company is on its MRK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data